Per Odin

111 – 120 of 161

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/med-poi?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
11
12
13
14
…
17
next »

2016
Mark Praktische Anwendung der Levodopa-Pumpe
Südmeyer, M ; Ebersbach, G ; Holtmann, M ; Jost, W ; Odin, P ^LU ; Schrader, C and Winkler, C ^LU (2016) In Fortschritte der Neurologie-Psychiatrie 84(7). p.10-404
- Contribution to journal › Scientific review
Mark Non-oral Continuous Drug Delivery Techniques in Parkinson's Disease : For Whom, When, and How?
Timpka, Jonathan ^LU ; Henriksen, Tove and Odin, Per ^LU (2016) In Movement Disorders Clinical Practice 3(3). p.221-229
- Contribution to journal › Scientific review
Mark Non-oral dopaminergic therapies for Parkinson's disease : current treatments and the future
Ray Chaudhuri, K ; Qamar, Mubasher A ; Rajah, Thadshani ; Loehrer, Philipp ; Sauerbier, Anna ; Odin, Per ^LU and Jenner, Peter (2016) In npj Parkinson's Disease 2. p.1-7
- Contribution to journal › Scientific review
Mark Oral and infusion levodopa therapy in the management of Parkinson’s disease
Angela Cenci-Nilsson, M. ^LU and Odin, Per ^LU (2016) p.63-75
- Chapter in Book/Report/Conference proceeding › Book chapter
Mark Levodopa–Carbidopa Intestinal Gel in Patients with Parkinson’s Disease : A Systematic Review
Wirdefeldt, Karin ; Odin, Per ^LU and Nyholm, Dag (2016) In CNS Drugs 30(5). p.381-404
- Contribution to journal › Scientific review
Mark A European multicentre survey of impulse control behaviours in Parkinson's disease patients treated with short- and long-acting dopamine agonists
Rizos, A. ; Sauerbier, A. ; Antonini, A. ; Weintraub, D. ; Martinez-Martin, P. ; Kessel, B. ; Henriksen, T. ; Falup-Pecurariu, C. ; Silverdale, M. and Durner, G. , et al. (2016) In European Journal of Neurology 23(8). p.1255-1261
- Contribution to journal › Article
2015
Mark Cost-effectiveness of continuous subcutaneous apomorphine in the treatment of Parkinson's disease in the UK and Germany
Walter, Evelyn and Odin, Per ^LU (2015) In Journal of Medical Economics 18(2). p.155-165
- Contribution to journal › Article
Mark Quantitative assessment of non-motor fluctuations in Parkinson's disease using the Non-Motor Symptoms Scale (NMSS)
Storch, Alexander ; Schneider, Christine B. ; Klingelhoefer, Lisa ; Odin, Per ^LU ; Fuchs, Gerd ; Jost, Wolfgang H. ; Martinez-Martin, Pablo ; Koch, Rainer ; Reichmann, Heinz and Chaudhuri, K. Ray , et al. (2015) In Journal of Neural Transmission 122(12). p.1673-1684
- Contribution to journal › Article
Mark Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease - Clinical practice recommendations
Trenkwalder, Claudia ; Chaudhuri, K. Ray ; Garcia Ruiz, Pedro J. ; LeWitt, Peter ; Katzenschlager, Regina ; Sixel-Doering, Friederike ; Henriksen, Tove ; Sesar, Angel ; Poewe, Werner and Baker, Mary , et al. (2015) In Parkinsonism & Related Disorders 21(9). p.1023-1030
- Contribution to journal › Scientific review
Mark Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: Consensus from an international survey and discussion program.
Odin, Per ^LU ; Ray Chaudhuri, K ; Slevin, J T ; Volkmann, J ; Dietrichs, E ; Martinez-Martin, P ; Krauss, J K ; Henriksen, T ; Katzenschlager, R and Antonini, A , et al. (2015) In Parkinsonism & Related Disorders 21(10). p.1133-1144
- Contribution to journal › Scientific review

« previous
1
…
11
12
13
14
…
17
next »